Literature DB >> 12530364

The morbidity of Guillain-Barré syndrome admitted to the intensive care unit.

R D Henderson1, N D Lawn, D D Fletcher, R L McClelland, E F M Wijdicks.   

Abstract

Patients with severe forms of Guillain-Barré syndrome (GBS) require intensive care. Specific treatment, catheterization, and devices may increase morbidity in the intensive care unit (ICU). To understand the spectrum of morbidity associated with ICU care, the authors studied 114 patients with GBS. Major morbidity occurred in 60% of patients. Complications were uncommon if ICU stay was less than 3 weeks. Respiratory complications such as pneumonia and tracheobronchitis occurred in half of the patients and were linked to mechanical ventilation. Systemic infection occurred in one-fifth of patients and was more frequent with increasing duration of ICU admission. Direct complications of treatment and invasive procedures occurred infrequently. Life-threatening complications such as gastrointestinal bleeding and pulmonary embolism were very uncommon. Pulmonary morbidity predominates in patients with severe GBS admitted to the ICU. Attention to management of mechanical ventilation and weaning is important to minimize this complication of GBS. Other causes of morbidity in a tertiary center ICU are uncommon.

Entities:  

Mesh:

Year:  2003        PMID: 12530364     DOI: 10.1212/01.wnl.0000035640.84053.5b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  EMG and duration of ventilatory support in children with Guillain-Barre syndrome.

Authors:  Fernando Ortiz-Corredor; Jorge Díaz-Ruiz; Alvaro Izquierdo-Bello
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

2.  Variants of Guillain-Barré syndrome: low incidence but high impact.

Authors:  Helmar C Lehmann; Hans-Peter Hartung
Journal:  J Neurol       Date:  2009-07-25       Impact factor: 4.849

Review 3.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

4.  Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome.

Authors:  David Orlikowski; Tarek Sharshar; Raphael Porcher; Djillali Annane; Jean Claude Raphael; Bernard Clair
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

Review 5.  Respiratory dysfunction in Guillain-Barré Syndrome.

Authors:  David Orlikowski; Hélène Prigent; Tarek Sharshar; Frédéric Lofaso; Jean Claude Raphael
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation.

Authors:  J Witsch; N Galldiks; A Bender; R Kollmar; J Bösel; C Hobohm; A Günther; I Schirotzek; K Fuchs; E Jüttler
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

7.  Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign.

Authors:  A Laufer Halpin; W Gu; M E Wise; J J Sejvar; R M Hoekstra; B E Mahon
Journal:  Epidemiol Infect       Date:  2018-07-10       Impact factor: 2.451

8.  Selective digestive tract decontamination decreases time on ventilator in Guillain-Barré syndrome.

Authors:  Martine E Bos Eyssen; Pieter A van Doorn; Bart C Jacobs; Ewout W Steyerberg; Peter H J van der Voort; Durk F Zandstra; Janneke Horn; Peter E Spronk; Cornelia W Hoedemaekers; Jan Bakker; Mathieu van der Jagt
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 9.  Update on respiratory management of critically ill neurologic patients.

Authors:  Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

Review 10.  Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.